Orbia Advance Corporation, S.A.B. de C.V. (MXCHF)
OTCMKTS · Delayed Price · Currency is USD
0.6500
-0.0306 (-4.49%)
Aug 4, 2025, 2:29 PM EDT
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -156 | 145 | 65 | 567 | 657 | 195 | Upgrade |
Depreciation & Amortization | 671 | 659 | 610 | 581 | 598 | 598 | Upgrade |
Loss (Gain) From Sale of Assets | -8 | -5 | -7 | -2 | 6 | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 8 | 136 | 14 | 8 | Upgrade |
Loss (Gain) on Equity Investments | - | - | -2 | -3 | -1 | -1 | Upgrade |
Other Operating Activities | 349 | 25 | 504 | 179 | 579 | 266 | Upgrade |
Change in Accounts Receivable | -84 | -28 | 139 | 107 | -318 | 57 | Upgrade |
Change in Inventory | -12 | 47 | 115 | -33 | -455 | -28 | Upgrade |
Change in Accounts Payable | 161 | 27 | -145 | -204 | 210 | 63 | Upgrade |
Change in Other Net Operating Assets | -116 | -89 | 110 | -42 | -54 | -75 | Upgrade |
Operating Cash Flow | 805 | 781 | 1,397 | 1,287 | 1,236 | 1,093 | Upgrade |
Operating Cash Flow Growth | -15.26% | -44.09% | 8.55% | 4.13% | 13.08% | 0.93% | Upgrade |
Capital Expenditures | -309 | -405 | -589 | -470 | -286 | -204 | Upgrade |
Sale of Property, Plant & Equipment | 48 | 37 | 10 | 11 | 18 | 21 | Upgrade |
Cash Acquisitions | -1 | -1 | -8 | -225 | -48 | - | Upgrade |
Sale (Purchase) of Intangibles | -120 | -67 | -95 | -67 | -27 | -31 | Upgrade |
Investment in Securities | -11 | -11 | -14 | -11 | - | -4 | Upgrade |
Other Investing Activities | 10 | - | - | - | - | - | Upgrade |
Investing Cash Flow | -383 | -447 | -696 | -762 | -343 | -218 | Upgrade |
Long-Term Debt Issued | - | 300 | 797 | 1,908 | 1,589 | 1,468 | Upgrade |
Long-Term Debt Repaid | - | -460 | -820 | -865 | -1,781 | -1,385 | Upgrade |
Net Debt Issued (Repaid) | 140 | -160 | -23 | 1,043 | -192 | 83 | Upgrade |
Repurchase of Common Stock | - | - | - | -142 | -165 | -42 | Upgrade |
Common Dividends Paid | -80 | -160 | -240 | -299 | -200 | -230 | Upgrade |
Other Financing Activities | -372 | -420 | -514 | -399 | -406 | -373 | Upgrade |
Financing Cash Flow | -312 | -740 | -777 | 203 | -963 | -562 | Upgrade |
Foreign Exchange Rate Adjustments | -48 | -41 | -14 | 36 | -23 | -24 | Upgrade |
Net Cash Flow | 62 | -447 | -90 | 764 | -93 | 289 | Upgrade |
Free Cash Flow | 496 | 376 | 808 | 817 | 950 | 889 | Upgrade |
Free Cash Flow Growth | 18.09% | -53.46% | -1.10% | -14.00% | 6.86% | 8.16% | Upgrade |
Free Cash Flow Margin | 6.66% | 5.01% | 9.85% | 8.47% | 10.82% | 13.85% | Upgrade |
Free Cash Flow Per Share | 0.26 | 0.20 | 0.42 | 0.43 | 0.48 | 0.44 | Upgrade |
Cash Interest Paid | 236 | 287 | 388 | 258 | 271 | 231 | Upgrade |
Cash Income Tax Paid | 154 | 176 | 371 | 488 | 243 | 281 | Upgrade |
Levered Free Cash Flow | 123.38 | 365.63 | 406.88 | 480.25 | 770.63 | 564.11 | Upgrade |
Unlevered Free Cash Flow | 364.63 | 613.13 | 650 | 658.38 | 925.63 | 713.49 | Upgrade |
Change in Net Working Capital | 138 | -103 | -174 | 220 | 275 | 135.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.